Compare OBIO & REA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OBIO | REA |
|---|---|---|
| Founded | 2017 | N/A |
| Country | United States | |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Metal Mining |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 253.9M | 232.3M |
| IPO Year | 2020 | 2026 |
| Metric | OBIO | REA |
|---|---|---|
| Price | $5.43 | $13.45 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $14.25 | N/A |
| AVG Volume (30 Days) | ★ 274.5K | 109.7K |
| Earning Date | 05-11-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 33.13 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $33,482,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $12.43 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 1169.22 | N/A |
| 52 Week Low | $2.20 | $8.95 |
| 52 Week High | $5.78 | $17.84 |
| Indicator | OBIO | REA |
|---|---|---|
| Relative Strength Index (RSI) | 75.80 | 51.74 |
| Support Level | $4.07 | $10.92 |
| Resistance Level | N/A | $15.82 |
| Average True Range (ATR) | 0.29 | 1.02 |
| MACD | 0.15 | 0.32 |
| Stochastic Oscillator | 82.11 | 64.54 |
Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. It has one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies.
Rare Earths Americas Inc is an exploration stage company focused on advancing projects related to rare earth minerals. Its activities include evaluating mineralization and assessing the characteristics and economic potential of its assets. Its portfolio includes the Shiloh Project in Georgia, United States; the Alpha Project in Bahia, Brazil; and the Constellation Project in Minas Gerais, Brazil. It also holds additional early-stage exploration projects, including the Homer Project in Goiás, Brazil, and the Liberty Peak Project in Georgia, United States. The company has two reportable segments due to their geographical location: United States Mining Operations and Brazil Mining Operations.